{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:10:54Z","timestamp":1793945454695,"version":"4.8.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41390-024-03689-0","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T20:10:49Z","timestamp":1731096649000},"page":"1327-1336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Promises and challenges of genomic newborn screening (NBS) \u2013 lessons from public health NBS programs"],"prefix":"10.1038","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6425-7137","authenticated-orcid":false,"given":"Mari","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimal P.","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margie A.","family":"Ream","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"3689_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/ijns8040062","volume":"8","author":"MH Gelb","year":"2022","unstructured":"Gelb, M. H. et al. Liquid Chromatography\u2013Tandem Mass Spectrometry in Newborn Screening Laboratories. Int J. Neonatal Screen 8, 62 (2022).","journal-title":"Int J. Neonatal Screen"},{"key":"3689_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.26.1.1","volume":"26","author":"WE Knox","year":"1960","unstructured":"Knox, W. E. An Evaluation Of The Treatment Of Phenylketonuria With Diets Low In Phenylalanine. Pediatrics 26, 1\u201311 (1960).","journal-title":"Pediatrics"},{"key":"3689_CR3","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2105\/AJPH.54.12.2075","volume":"54","author":"RA MacCready","year":"1964","unstructured":"MacCready, R. A. & Hussey, M. G. Newborn Phenylketonuria Detection Program in Massachusetts. Am. J. Public Health Nations Health 54, 2075\u20132081 (1964).","journal-title":"Am. J. Public Health Nations Health"},{"key":"3689_CR4","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM196406252702602","volume":"270","author":"ML Efron","year":"1964","unstructured":"Efron, M. L., Young, D., Moser, H. W. & MacCready, R. A. A Simple Chromatographic Screening Test for the Detection of Disorders of Amino Acid Metabolism: A Technic Using Whole Blood or Urine Collected on Filter Paper. N. Engl. J. Med. 270, 1378\u20131383 (1964).","journal-title":"N. Engl. J. Med"},{"key":"3689_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1542\/peds.32.3.338","volume":"32","author":"R Guthrie","year":"1963","unstructured":"Guthrie, R. & Susi, A. A Simple Phenylalanine Method For Detecting Phenylketonuria In Large Populations Of Newborn Infants. Pediatrics 32, 338\u2013343 (1963).","journal-title":"Pediatrics"},{"key":"3689_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0300-595X(74)80031-9","volume":"3","author":"HL Levy","year":"1974","unstructured":"Levy, H. L. 10 Neonatal screening for inborn errors of amino acid metabolism. Clin. Endocrinol. Metab. 3, 153\u2013166 (1974).","journal-title":"Clin. Endocrinol. Metab."},{"key":"3689_CR7","doi-asserted-by":"publisher","unstructured":"Levy, H. L. Genetic Screening. in Advances in Human Genetics (eds. Harris, H. & Hirschhorn, K.) 1\u2013104 (Springer US, Boston, MA, 1973). https:\/\/doi.org\/10.1007\/978-1-4615-8261-8_1.","DOI":"10.1007\/978-1-4615-8261-8_1"},{"key":"3689_CR8","unstructured":"Wilson, J. M. G. & Jungner, G. PRINCIPLES AND PRACTICE OF SCREENING FOR DISEASE. (1968)."},{"key":"3689_CR9","unstructured":"Committee for the Study of Inborn Errors of Metabolism. Genetic Screening Programs, Principles, and Research. (Natl. Acad. Sci., 1975)."},{"key":"3689_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev.med.59.110106.132016","volume":"59","author":"LL McCabe","year":"2008","unstructured":"McCabe, L. L. & McCabe, E. R. B. Expanded Newborn Screening: Implications for Genomic Medicine. Annu. Rev. Med. 59, 163\u2013175 (2008).","journal-title":"Annu. Rev. Med."},{"key":"3689_CR11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1542\/peds.58.5.757","volume":"58","author":"ATF Screening","year":"1976","unstructured":"Screening, A. T. F. The Pediatrician and Genetic Screening (Every Pediatrician a Geneticist). Pediatrics 58, 757\u2013764 (1976). on G.","journal-title":"Pediatrics"},{"key":"3689_CR12","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1542\/peds.111.6.1399","volume":"111","author":"A Schulze","year":"2003","unstructured":"Schulze, A. et al. Expanded Newborn Screening for Inborn Errors of Metabolism by Electrospray Ionization-Tandem Mass Spectrometry: Results, Outcome, and Implications. PEDIATRICS 111, 1399\u20131406 (2003).","journal-title":"PEDIATRICS"},{"key":"3689_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s10545-006-0228-9","volume":"29","author":"DM Frazier","year":"2006","unstructured":"Frazier, D. M. et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997\u20132005. J. Inherit. Metab. Dis. 29, 76\u201385 (2006).","journal-title":"J. Inherit. Metab. Dis."},{"key":"3689_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jama.2014.9132","volume":"312","author":"A Kwan","year":"2014","unstructured":"Kwan, A. et al. Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States. JAMA 312, 729\u2013738 (2014).","journal-title":"JAMA"},{"key":"3689_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1373\/clinchem.2009.141622","volume":"56","author":"D Marsden","year":"2010","unstructured":"Marsden, D. & Levy, H. Newborn Screening of Lysosomal Storage Disorders. Clin. Chem. 56, 1071\u20131079 (2010).","journal-title":"Clin. Chem."},{"key":"3689_CR16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1373\/clinchem.2012.189936","volume":"59","author":"Z Spacil","year":"2013","unstructured":"Spacil, Z. et al. High-Throughput Assay of 9 Lysosomal Enzymes for Newborn Screening. Clin. Chem. 59, 502\u2013511 (2013).","journal-title":"Clin. Chem."},{"key":"3689_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.10.012","volume":"25","author":"MA Ream","year":"2023","unstructured":"Ream, M. A. et al. Evidence and recommendation for mucopolysaccharidosis type II newborn screening in the United States. Genet. Med. 25, 100330 (2023).","journal-title":"Genet. Med."},{"key":"3689_CR18","unstructured":"Kemper, A. R. et al. Evidence report: newborn screening for Pompe disease. Report Date: 03 June 2013 Accessed via HRSA.gov on October 30, 2024."},{"key":"3689_CR19","unstructured":"Kemper, A. R., et al. Evidence-Based Review of Newborn Screening for Krabbe Disease Final Report: February 1, 2024. Accessed via HRSA.gov on October 30, 2024."},{"key":"3689_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/ijns5040039","volume":"5","author":"C Gutierrez-Mateo","year":"2019","unstructured":"Gutierrez-Mateo, C. et al. Development of a Multiplex Real-Time PCR Assay for the Newborn Screening of SCID, SMA, and XLA. Int. J. Neonatal Screen. 5, 39 (2019).","journal-title":"Int. J. Neonatal Screen."},{"key":"3689_CR21","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.15585\/mmwr.mm6936a6","volume":"69","author":"MK Sontag","year":"2020","unstructured":"Sontag, M. K. et al. Infants with Congenital Disorders Identified Through Newborn Screening \u2014 United States, 2015\u20132017. MMWR Morb. Mortal. Wkly. Rep. 69, 1265\u20131268 (2020).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"3689_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/01.gim.0000223891.82390.ad","volume":"8","author":"MS Watson","year":"2006","unstructured":"Watson, M. S., Mann, M. Y., Lloyd-Puryear, M. A., Rinaldo, P. & Howell, R. R. Executive Summary: Newborn screening: toward a uniform screening panel and system. Genet. Med. 8, S1\u2013S11 (2006).","journal-title":"Genet. Med."},{"key":"3689_CR23","doi-asserted-by":"publisher","unstructured":"Bick, S. L. et al. Estimating the sensitivity of genomic newborn screening for treatable inherited metabolic disorders. Genet. Med. 101284 https:\/\/doi.org\/10.1016\/j.gim.2024.101284. (2024)","DOI":"10.1016\/j.gim.2024.101284"},{"key":"3689_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/bdr2.1653","volume":"112","author":"SE McCandless","year":"2020","unstructured":"McCandless, S. E. & Wright, E. J. Mandatory newborn screening in the United States: History, current status, and existential challenges. Birth Defects Res. 112, 350\u2013366 (2020).","journal-title":"Birth Defects Res."},{"key":"3689_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.pcl.2018.12.007","volume":"66","author":"NAV Fabie","year":"2019","unstructured":"Fabie, N. A. V., Pappas, K. B. & Feldman, G. L. The Current State of Newborn Screening in the United States. Pediatr. Clin. North Am. 66, 369\u2013386 (2019).","journal-title":"Pediatr. Clin. North Am."},{"key":"3689_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijns4030023","volume":"4","author":"MH Gelb","year":"2018","unstructured":"Gelb, M. H. Newborn Screening for Lysosomal Storage Diseases: Methodologies, Screen Positive Rates, Normalization of Datasets, Second-Tier Tests, and Post-Analysis Tools. Int. J. Neonatal Screen. 4, 23 (2018).","journal-title":"Int. J. Neonatal Screen."},{"key":"3689_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijns9020020","volume":"9","author":"S Singh","year":"2023","unstructured":"Singh, S., Ojodu, J., Kemper, A. R., Lam, W. K. K. & Grosse, S. D. Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010\u20132018. Int. J. Neonatal Screen. 9, 20 (2023).","journal-title":"Int. J. Neonatal Screen."},{"key":"3689_CR28","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1542\/peds.2016-0280D","volume":"140","author":"BK Burton","year":"2017","unstructured":"Burton, B. K., Kronn, D. F., Hwu, W.-L. & Kishnani, P. S. The Initial Evaluation of Patients After Positive Newborn Screening: Recommended Algorithms Leading to a Confirmed Diagnosis of Pompe Disease. Pediatrics 140, S14\u2013S23 (2017).","journal-title":"Pediatrics"},{"key":"3689_CR29","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1542\/peds.2016-0280E","volume":"140","author":"DF Kronn","year":"2017","unstructured":"Kronn, D. F. et al. Management of Confirmed Newborn-Screened Patients With Pompe Disease Across the Disease Spectrum. Pediatrics 140, S24\u2013S45 (2017).","journal-title":"Pediatrics"},{"key":"3689_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jpeds.2016.11.036","volume":"182","author":"LA Clarke","year":"2017","unstructured":"Clarke, L. A. et al. Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management. J. Pediatrics 182, 363\u2013370 (2017).","journal-title":"J. Pediatrics"},{"key":"3689_CR31","doi-asserted-by":"publisher","unstructured":"Thompson-Stone, R. et al. Consensus recommendations for the classification and long-term follow up of infants who screen positive for Krabbe Disease. Mol. Genet. Metab. https:\/\/doi.org\/10.1016\/j.ymgme.2021.03.016. (2021)","DOI":"10.1016\/j.ymgme.2021.03.016"},{"key":"3689_CR32","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1210\/jc.2018-00920","volume":"103","author":"MO Regelmann","year":"2018","unstructured":"Regelmann, M. O. et al. Adrenoleukodystrophy: Guidance for Adrenal Surveillance in Males Identified by Newborn Screen. J. Clin. Endocrinol. Metab. 103, 4324\u20134331 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3689_CR33","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/jimd.12356","volume":"44","author":"EJ Mallack","year":"2021","unstructured":"Mallack, E. J. et al. MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines. J. Inherit. Metab. Dis. 44, 728\u2013739 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"key":"3689_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JND-180304","volume":"5","author":"J Glascock","year":"2018","unstructured":"Glascock, J. et al. Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening. JND 5, 145\u2013158 (2018).","journal-title":"JND"},{"key":"3689_CR35","doi-asserted-by":"crossref","unstructured":"Glascock, J. et al. Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2. J Neuromuscul. Dis. 7, 97\u2013100.","DOI":"10.3233\/JND-190468"},{"key":"3689_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/brain\/awt361","volume":"137","author":"M Engelen","year":"2014","unstructured":"Engelen, M. et al. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. Brain 137, 693\u2013706 (2014).","journal-title":"Brain"},{"key":"3689_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-6","volume":"9","author":"CT Habekost","year":"2014","unstructured":"Habekost, C. T. et al. Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristics. Orphanet J. Rare Dis. 9, 6 (2014).","journal-title":"Orphanet J. Rare Dis."},{"key":"3689_CR38","doi-asserted-by":"publisher","first-page":"107734","DOI":"10.1016\/j.ymgme.2023.107734","volume":"140","author":"C Videb\u00e6k","year":"2023","unstructured":"Videb\u00e6k, C., Melgaard, L., Lund, A. M. & Gr\u00f8nborg, S. W. Newborn screening for adrenoleukodystrophy: International experiences and challenges. Mol. Genet. Metab. 140, 107734 (2023).","journal-title":"Mol. Genet. Metab."},{"key":"3689_CR39","doi-asserted-by":"publisher","unstructured":"Wang, M. Next-Generation Sequencing (NGS). in Clinical Molecular Diagnostics (eds. Pan, S. & Tang, J.) 305\u2013327 (Springer, Singapore). https:\/\/doi.org\/10.1007\/978-981-16-1037-0_23., (2021).","DOI":"10.1007\/978-981-16-1037-0_23"},{"key":"3689_CR40","doi-asserted-by":"publisher","unstructured":"Manickam, K. et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 1\u20139 https:\/\/doi.org\/10.1038\/s41436-021-01242-6. (2021)","DOI":"10.1038\/s41436-021-01242-6"},{"key":"3689_CR41","doi-asserted-by":"publisher","unstructured":"Souche, E. et al. Recommendations for whole genome sequencing in diagnostics for rare diseases. Eur. J. Hum. Genet. 1\u20135 https:\/\/doi.org\/10.1038\/s41431-022-01113-x. (2022)","DOI":"10.1038\/s41431-022-01113-x"},{"key":"3689_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41525-024-00410-2","volume":"9","author":"V Jobanputra","year":"2024","unstructured":"Jobanputra, V. et al. Advancing access to genome sequencing for rare genetic disorders: recent progress and call to action. npj Genom. Med. 9, 1\u20133 (2024).","journal-title":"npj Genom. Med."},{"key":"3689_CR43","doi-asserted-by":"crossref","unstructured":"Guo, F. et al. Evidence from 2100 index cases supports genome sequencing as a first-tier genetic test. Genet. Med. 26, 100995 (2024).","DOI":"10.1016\/j.gim.2023.100995"},{"key":"3689_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.09.017","volume":"25","author":"G Raca","year":"2023","unstructured":"Raca, G. et al. Points to consider in the detection of germline structural variants using next-generation sequencing: A statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 25, 100316 (2023).","journal-title":"Genet. Med."},{"key":"3689_CR45","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41436-021-01139-4","volume":"23","author":"C Rehder","year":"2021","unstructured":"Rehder, C. et al. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 23, 1399\u20131415 (2021).","journal-title":"Genet. Med."},{"key":"3689_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013423 (2015).","journal-title":"Genet. Med."},{"key":"3689_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","volume":"22","author":"ER Riggs","year":"2020","unstructured":"Riggs, E. R. et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet. Med. 22, 245\u2013257 (2020).","journal-title":"Genet. Med."},{"key":"3689_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01073-3","volume":"14","author":"JM Ellingford","year":"2022","unstructured":"Ellingford, J. M. et al. Recommendations for clinical interpretation of variants found in non-coding regions of the genome. Genome Med. 14, 73 (2022).","journal-title":"Genome Med."},{"key":"3689_CR49","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res"},{"key":"3689_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0688-9","volume":"11","author":"SM Harrison","year":"2019","unstructured":"Harrison, S. M. & Rehm, H. L. Is \u2018likely pathogenic\u2019 really 90% likely? Reclassification data in ClinVar. Genome Med. 11, 72 (2019).","journal-title":"Genome Med."},{"key":"3689_CR51","doi-asserted-by":"publisher","first-page":"e2339571","DOI":"10.1001\/jamanetworkopen.2023.39571","volume":"6","author":"E Chen","year":"2023","unstructured":"Chen, E. et al. Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing. JAMA Netw. Open 6, e2339571 (2023).","journal-title":"JAMA Netw. Open"},{"key":"3689_CR52","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3390\/genes12121885","volume":"12","author":"F Cristofoli","year":"2021","unstructured":"Cristofoli, F. et al. Variant Selection and Interpretation: An Example of Modified VarSome Classifier of ACMG Guidelines in the Diagnostic Setting. Genes 12, 1885 (2021).","journal-title":"Genes"},{"key":"3689_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100830","volume":"25","author":"L Meng","year":"2023","unstructured":"Meng, L. et al. Evaluation of an automated genome interpretation model for rare disease routinely used in a clinical genetic laboratory. Genet. Med. 25, 100830 (2023).","journal-title":"Genet. Med."},{"key":"3689_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41525-020-0137-0","volume":"5","author":"S Rockowitz","year":"2020","unstructured":"Rockowitz, S. et al. Children\u2019s rare disease cohorts: an integrative research and clinical genomics initiative. npj Genom. Med. 5, 1\u201312 (2020).","journal-title":"npj Genom. Med."},{"key":"3689_CR55","doi-asserted-by":"publisher","first-page":"eaat6177","DOI":"10.1126\/scitranslmed.aat6177","volume":"11","author":"MM Clark","year":"2019","unstructured":"Clark, M. M. et al. Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation. Sci. Transl. Med. 11, eaat6177 (2019).","journal-title":"Sci. Transl. Med."},{"key":"3689_CR56","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00439-020-02216-5","volume":"140","author":"C Lee","year":"2021","unstructured":"Lee, C., Yen, H.-Y., Zhong, A. W. & Gao, H. Resolving misalignment interference for NGS-based clinical diagnostics. Hum. Genet 140, 477\u2013492 (2021).","journal-title":"Hum. Genet"},{"key":"3689_CR57","unstructured":"Ibanez, K. et al. Whole Genome Sequencing for Diagnosis of Neurological Repeat Expansion Disorders. http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2020.11.06.371716 (2020)."},{"key":"3689_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41576-018-0092-0","volume":"20","author":"D Monk","year":"2019","unstructured":"Monk, D., Mackay, D. J. G., Eggermann, T., Maher, E. R. & Riccio, A. Genomic imprinting disorders: lessons on how genome, epigenome and environment interact. Nat. Rev. Genet. 20, 235 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"3689_CR59","doi-asserted-by":"crossref","unstructured":"Nakabayashi, K. Chapter Seven - The Illumina Infinium methylation assay for genome-wide methylation analyses. in Epigenetics Methods (ed. Tollefsbol, T.) vol. 19 117\u2013140 (Academic Press, 2020).","DOI":"10.1016\/B978-0-12-819414-0.00007-0"},{"key":"3689_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53449-y","volume":"9","author":"Y Yao","year":"2019","unstructured":"Yao, Y. et al. A simple method for sequencing the whole human mitochondrial genome directly from samples and its application to genetic testing. Sci. Rep. 9, 17411 (2019).","journal-title":"Sci. Rep."},{"key":"3689_CR61","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijns10010006","volume":"10","author":"F Lynch","year":"2024","unstructured":"Lynch, F. et al. Australian Public Perspectives on Genomic Newborn Screening: Risks, Benefits, and Preferences for Implementation. Int. J. Neonatal Screen. 10, 6 (2024).","journal-title":"Int. J. Neonatal Screen."},{"key":"3689_CR62","unstructured":"Bovbjerg, M. L. Screening and Diagnostic Testing. (2020)."},{"key":"3689_CR63","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/gim.2015.111","volume":"18","author":"DL Bodian","year":"2016","unstructured":"Bodian, D. L. et al. Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates. Genet. Med. 18, 221\u2013230 (2016).","journal-title":"Genet. Med."},{"key":"3689_CR64","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41591-020-0966-5","volume":"26","author":"AN Adhikari","year":"2020","unstructured":"Adhikari, A. N. et al. The role of exome sequencing in newborn screening for inborn errors of metabolism. Nat. Med. 26, 1392\u20131397 (2020).","journal-title":"Nat. Med."},{"key":"3689_CR65","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijns10010020","volume":"10","author":"G Kiewiet","year":"2024","unstructured":"Kiewiet, G. et al. Future of Dutch NGS-Based Newborn Screening: Exploring the Technical Possibilities and Assessment of a Variant Classification Strategy. Int. J. Neonatal Screen. 10, 20 (2024).","journal-title":"Int. J. Neonatal Screen."},{"key":"3689_CR66","doi-asserted-by":"publisher","unstructured":"Minten, T. et al. Determining the characteristics of genetic disorders that predict inclusion in newborn genomic sequencing programs. Preprint at https:\/\/doi.org\/10.1101\/2024.03.24.24304797 (2024).","DOI":"10.1101\/2024.03.24.24304797"},{"key":"3689_CR67","doi-asserted-by":"publisher","unstructured":"Downie, L. et al. Gene selection for genomic newborn screening: moving towards consensus? Genet. Med. 101077 https:\/\/doi.org\/10.1016\/j.gim.2024.101077. (2024)","DOI":"10.1016\/j.gim.2024.101077"},{"key":"3689_CR68","doi-asserted-by":"publisher","first-page":"e2114336","DOI":"10.1001\/jamanetworkopen.2021.14336","volume":"4","author":"L Downie","year":"2021","unstructured":"Downie, L., Halliday, J., Lewis, S. & Amor, D. J. Principles of Genomic Newborn Screening Programs: A Systematic Review. JAMA Netw. Open 4, e2114336 (2021).","journal-title":"JAMA Netw. Open"},{"key":"3689_CR69","doi-asserted-by":"publisher","first-page":"e2312231","DOI":"10.1001\/jamanetworkopen.2023.12231","volume":"6","author":"NB Gold","year":"2023","unstructured":"Gold, N. B. et al. Perspectives of Rare Disease Experts on Newborn Genome Sequencing. JAMA Netw. Open 6, e2312231 (2023).","journal-title":"JAMA Netw. Open"},{"key":"3689_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00867-1","volume":"13","author":"DM DeCristo","year":"2021","unstructured":"DeCristo, D. M. et al. Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making. Genome Med. 13, 50 (2021).","journal-title":"Genome Med."},{"key":"3689_CR71","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajmg.c.31874","volume":"187","author":"D Bick","year":"2021","unstructured":"Bick, D. et al. An online compendium of treatable genetic disorders. Am. J. Med. Genet. Part C: Semin. Med. Genet. 187, 48\u201354 (2021).","journal-title":"Am. J. Med. Genet. Part C: Semin. Med. Genet."},{"key":"3689_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31446-6","volume":"13","author":"MJ Owen","year":"2022","unstructured":"Owen, M. J. et al. An automated 13.5\u2009h system for scalable diagnosis and acute management guidance for genetic diseases. Nat. Commun. 13, 4057 (2022).","journal-title":"Nat. Commun."},{"key":"3689_CR73","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/s41436-020-01083-9","volume":"23","author":"LJH Bean","year":"2021","unstructured":"Bean, L. J. H. et al. DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 23, 979\u2013988 (2021).","journal-title":"Genet. Med."},{"key":"3689_CR74","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/humu.23356","volume":"39","author":"L Bassaganyas","year":"2018","unstructured":"Bassaganyas, L. et al. Whole exome and whole genome sequencing with dried blood spot DNA without whole genome amplification. Hum. Mutat. 39, 167\u2013171 (2018).","journal-title":"Hum. Mutat."},{"key":"3689_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41525-023-00349-w","volume":"8","author":"Y Ding","year":"2023","unstructured":"Ding, Y. et al. Scalable, high quality, whole genome sequencing from archived, newborn, dried blood spots. npj Genom. Med. 8, 1\u20139 (2023).","journal-title":"npj Genom. Med."},{"key":"3689_CR76","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-020-2817-4","volume":"586","author":"ED Green","year":"2020","unstructured":"Green, E. D. et al. Strategic vision for improving human health at The Forefront of Genomics. Nature 586, 683\u2013693 (2020).","journal-title":"Nature"},{"key":"3689_CR77","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2252","volume":"139","author":"JS Berg","year":"2017","unstructured":"Berg, J. S. et al. Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics 139, e20162252 (2017).","journal-title":"Pediatrics"},{"key":"3689_CR78","doi-asserted-by":"publisher","unstructured":"Stark, Z. & Scott, R. H. Genomic newborn screening for rare diseases. Nat Rev Genet 1\u201312 https:\/\/doi.org\/10.1038\/s41576-023-00621-w. (2023)","DOI":"10.1038\/s41576-023-00621-w"},{"key":"3689_CR79","doi-asserted-by":"crossref","unstructured":"Bros-Facer, V., Taylor, S. & Patch, C. Next-generation sequencing-based newborn screening initiatives in Europe: an overview. Rare Dis Orphan Drugs J 2, (2023).","DOI":"10.20517\/rdodj.2023.26"},{"key":"3689_CR80","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2018.11.016","volume":"104","author":"O Ceyhan-Birsoy","year":"2019","unstructured":"Ceyhan-Birsoy, O. et al. Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project. Am. J. Hum. Genet. 104, 76\u201393 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"3689_CR81","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.ajhg.2023.05.007","volume":"110","author":"RC Green","year":"2023","unstructured":"Green, R. C. et al. Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project. Am. J. Hum. Genet. 110, 1034\u20131045 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"3689_CR82","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ajhg.2020.08.001","volume":"107","author":"TS Roman","year":"2020","unstructured":"Roman, T. S. et al. Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project. Am. J. Hum. Genet. 107, 596\u2013611 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"3689_CR83","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12887-019-1606-4","volume":"19","author":"DB Bailey","year":"2019","unstructured":"Bailey, D. B. et al. Early Check: translational science at the intersection of public health and newborn screening. BMC Pediatr. 19, 238 (2019).","journal-title":"BMC Pediatr."},{"key":"3689_CR84","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.ajhg.2022.08.003","volume":"109","author":"SF Kingsmore","year":"2022","unstructured":"Kingsmore, S. F. et al. A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases. Am. J. Hum. Genet. 109, 1605\u20131619 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"3689_CR85","doi-asserted-by":"publisher","first-page":"101043","DOI":"10.1016\/j.gimo.2024.101043","volume":"2","author":"J Schleit","year":"2024","unstructured":"Schleit, J. et al. P146: BeginNGS, an artificial intelligence-enabled genome sequencing system for newborn screening of 409 childhood genetic disorders*. Genet. Med. Open 2, 101043 (2024).","journal-title":"Genet. Med. Open"},{"key":"3689_CR86","unstructured":"Chung, W. et al. O35: Feasibility of expanded newborn screening using genome sequencing for early actionable conditions in a diverse city. Genet. Med. Open 2, (2024)."},{"key":"3689_CR87","doi-asserted-by":"publisher","first-page":"e081426","DOI":"10.1136\/bmjopen-2023-081426","volume":"14","author":"S Lunke","year":"2024","unstructured":"Lunke, S. et al. Prospective cohort study of genomic newborn screening: BabyScreen+ pilot study protocol. BMJ Open 14, e081426 (2024).","journal-title":"BMJ Open"},{"key":"3689_CR88","unstructured":"Network, W. and C. H. NewbornsInSA Research Study. Women\u2019s and Children\u2019s Hospital https:\/\/www.wch.sa.gov.au\/research\/newbornsinsa-research-study."},{"key":"3689_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02916-x","volume":"18","author":"A Ferlini","year":"2023","unstructured":"Ferlini, A. et al. Rare diseases\u2019 genetic newborn screening as the gateway to future genomic medicine: the Screen4Care EU-IMI project. Orphanet J. Rare Dis. 18, 310 (2023).","journal-title":"Orphanet J. Rare Dis."},{"key":"3689_CR90","unstructured":"https:\/\/www.klinikum.uni-heidelberg.de\/en\/new-lives-genomic-newborn-screening-programs Universit\u00e4tsklinikum Heidelberg: NEW_LIVES: Genomic Newborn Screening Programs."},{"key":"3689_CR91","doi-asserted-by":"publisher","unstructured":"Horton, R. et al. Challenges of using whole genome sequencing in population newborn screening. BMJ e077060 https:\/\/doi.org\/10.1136\/bmj-2023-077060. (2024)","DOI":"10.1136\/bmj-2023-077060"},{"key":"3689_CR92","doi-asserted-by":"publisher","first-page":"866168","DOI":"10.3389\/fgene.2022.866168","volume":"13","author":"A Pichini","year":"2022","unstructured":"Pichini, A. et al. Developing a National Newborn Genomes Program: An Approach Driven by Ethics, Engagement and Co-design. Front Genet 13, 866168 (2022).","journal-title":"Front Genet"},{"key":"3689_CR93","doi-asserted-by":"publisher","first-page":"121259","DOI":"10.1016\/j.jns.2023.121259","volume":"455","author":"T Dangouloff","year":"2023","unstructured":"Dangouloff, T. et al. Baby detect: Universal genomic newborn screening for early, treatable, and severe conditions. J. Neurological Sci. 455, 121259 (2023).","journal-title":"J. Neurological Sci."},{"key":"3689_CR94","unstructured":"\u0391\u03c1\u03c7\u03b9\u03ba\u03ae. First Steps https:\/\/www.firststeps-ngs.gr."},{"key":"3689_CR95","doi-asserted-by":"publisher","first-page":"e2331162","DOI":"10.1001\/jamanetworkopen.2023.31162","volume":"6","author":"T Chen","year":"2023","unstructured":"Chen, T. et al. Genomic Sequencing as a First-Tier Screening Test and Outcomes of Newborn Screening. JAMA Netw. Open 6, e2331162 (2023).","journal-title":"JAMA Netw. Open"},{"key":"3689_CR96","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.0146","volume":"7","author":"D Marom","year":"2024","unstructured":"Marom, D. et al. National Rapid Genome Sequencing in Neonatal Intensive Care. JAMA Netw. Open 7, e240146 (2024).","journal-title":"JAMA Netw. Open"},{"key":"3689_CR97","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1542\/neo.25-3-e139","volume":"25","author":"K Seither","year":"2024","unstructured":"Seither, K., Thompson, W. & Suhrie, K. A Practical Guide to Whole Genome Sequencing in the NICU. NeoReviews 25, e139\u2013e150 (2024).","journal-title":"NeoReviews"},{"key":"3689_CR98","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41436-018-0293-0","volume":"21","author":"PJ van der Sluijs","year":"2019","unstructured":"van der Sluijs, P. J. et al. Putting genome-wide sequencing in neonates into perspective. Genet. Med. 21, 1074\u20131082 (2019).","journal-title":"Genet. Med."},{"key":"3689_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100866","volume":"25","author":"DT Miller","year":"2023","unstructured":"Miller, D. T. et al. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 25, 100866 (2023).","journal-title":"Genet. Med."},{"key":"3689_CR100","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41436-021-01203-z","volume":"23","author":"AR Gregg","year":"2021","unstructured":"Gregg, A. R. et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 23, 1793\u20131806 (2021).","journal-title":"Genet. Med."},{"key":"3689_CR101","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1542\/peds.2015-3731D","volume":"137","author":"JS King","year":"2016","unstructured":"King, J. S. & Smith, M. E. Whole-Genome Screening of Newborns? The Constitutional Boundaries of State Newborn Screening Programs. Pediatrics 137, S8\u2013S15 (2016).","journal-title":"Pediatrics"},{"key":"3689_CR102","doi-asserted-by":"publisher","first-page":"100821","DOI":"10.1016\/j.gimo.2023.100821","volume":"1","author":"SL Stenton","year":"2023","unstructured":"Stenton, S. L., Campagna, M., Philippakis, A., O\u2019Donnell-Luria, A. & Gelb, M. H. First-tier next-generation sequencing for newborn screening: An important role for biochemical second-tier testing. Genet. Med. Open 1, 100821 (2023).","journal-title":"Genet. Med. Open"},{"key":"3689_CR103","doi-asserted-by":"crossref","unstructured":"Fullerton, S. M., Phil, D. & Brothers, K. B. Expanding Applications of Clinical Genetic Testing \u2014 Ethical Challenges. N Engl J Med. (2024).","DOI":"10.1056\/NEJMp2311466"},{"key":"3689_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03111-2","volume":"19","author":"S Vaghela","year":"2024","unstructured":"Vaghela, S., Tanni, K. A., Banerjee, G. & Sikirica, V. A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet J. Rare Dis. 19, 117 (2024).","journal-title":"Orphanet J. Rare Dis."},{"key":"3689_CR105","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/GIM.0b013e3182147639","volume":"13","author":"BL Therrell Jr","year":"2011","unstructured":"Therrell Jr, B. L. et al. Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening. Genet. Med. 13, 621\u2013624 (2011).","journal-title":"Genet. Med."},{"key":"3689_CR106","unstructured":"DiFilippo, D. Civil rights group sues New Jersey to stop secret storage, use of baby blood spots \u2022 New Jersey Monitor. New Jersey Monitor https:\/\/newjerseymonitor.com\/2023\/11\/02\/civil-rights-group-sues-new-jersey-to-stop-secret-storage-use-of-baby-blood-spots\/ (2023)."},{"key":"3689_CR107","doi-asserted-by":"publisher","unstructured":"IV, R. H., Choudhury, S. & Shah, A. Newborn Screening Blood Spot Retention And Reuse: A Clash Of Public Health And Privacy Interests. Health Affairs Forefront https:\/\/doi.org\/10.1377\/forefront.20221004.177058.","DOI":"10.1377\/forefront.20221004.177058"},{"key":"3689_CR108","unstructured":"Faden, R. A survey to evaluate parental consent as public policy for neonatal screening. https:\/\/ajph.aphapublications.org\/doi\/epdf\/10.2105\/AJPH.72.12.1347."},{"key":"3689_CR109","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.2105\/AJPH.72.12.1396","volume":"72","author":"RR Faden","year":"1982","unstructured":"Faden, R. R., Holtzman, N. A. & Chwalow, A. J. Parental rights, child welfare, and public health: the case of PKU screening. Am. J. Public Health 72, 1396\u20131400 (1982).","journal-title":"Am. J. Public Health"},{"key":"3689_CR110","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/d41586-021-00313-7","volume":"590","author":"A Wonkam","year":"2021","unstructured":"Wonkam, A. Sequence three million genomes across Africa. Nature 590, 209\u2013211 (2021).","journal-title":"Nature"},{"key":"3689_CR111","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/ijns8040051","volume":"8","author":"RJ Currier","year":"2022","unstructured":"Currier, R. J. Newborn Screening Is on a Collision Course with Public Health Ethics. Int. J. Neonatal Screen. 8, 51 (2022).","journal-title":"Int. J. Neonatal Screen."},{"key":"3689_CR112","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41390-022-02240-3","volume":"93","author":"MH Wojcik","year":"2023","unstructured":"Wojcik, M. H. et al. Rare Diseases, Common Barriers: Disparities in Pediatric Clinical Genetics Outcomes. Pediatr. Res. 93, 110\u2013117 (2023).","journal-title":"Pediatr. Res"},{"key":"3689_CR113","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jama.2015.6175","volume":"314","author":"MJ Bayefsky","year":"2015","unstructured":"Bayefsky, M. J., Saylor, K. W. & Berkman, B. E. Parental Consent for the Use of Residual Newborn Screening Bloodspots: Respecting Individual Liberty vs Ensuring Public Health. JAMA 314, 21\u201322 (2015).","journal-title":"JAMA"},{"key":"3689_CR114","unstructured":"Suter, S. M. Did you give the government your baby's DNA? Rethinking consent in newborn screening. Minn. JL Sci. & Tech. 15, 729 (2014)."},{"key":"3689_CR115","unstructured":"Ram, N. America\u2019s Hidden National DNA Database. Tex. L. Rev. 100, 1253 (2021)."},{"key":"3689_CR116","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.forsciint.2010.09.024","volume":"205","author":"D Hartman","year":"2011","unstructured":"Hartman, D., Drummer, O., Eckhoff, C., Scheffer, J. W. & Stringer, P. The contribution of DNA to the disaster victim identification (DVI) effort. Forensic Sci. Int. 205, 52\u201358 (2011).","journal-title":"Forensic Sci. Int."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03689-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03689-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03689-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:02:40Z","timestamp":1748318560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03689-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":116,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3689"],"URL":"https:\/\/doi.org\/10.1038\/s41390-024-03689-0","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}